Clinical efficacy of fecal bacteria transplantation in the treatment of ulcerative colitis by reconstructing intestinal functional flora

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100046215

Enrollment

Unknown

Registered

2021-05-10

Start date

2021-10-01

Completion date

Unknown

Last updated

2021-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ulcerative colitis

Interventions

Experimental group:fecal bacteria transplantation

control group:conventional therapy

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with moderate to severe ulcerative colitis (Mayo score 6-12); 2. Aged >= 18 years; 3. Voluntarily participate and sign informed consent, and complete follow-up.

Exclusion criteria

Exclusion criteria: 1. Previous abdominal surgery history; 2. Taking antibiotics, probiotics or prebiotics in recent one month; 3. Severe heart, liver and kidney diseases; 4. Pregnant women.

Design outcomes

Primary

Measure	Time frame
Clinical remission rate;Clinical effective rate;	—

Secondary

Measure	Time frame
adverse reactions;Intestinal flora;Inflammatory factors;	—

Countries

China

Contacts

Public ContactGuo Shiqiang

The Affiliated Nanhai Hospital of Southern Medical University

liuchunalone@163.com+86 18923186116

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026